Exploring the RANK–RANKL–OPG axis in MASLD enhances our understanding of the disease and opens up promising avenues for therapeutic interventions across hepatology, endocrinology, and bone metabolism. The gene discussed is TNFRSF11B; the disease is metabolic dysfunction-associated steatotic liver disease.